Eli Lilly’s (LLY) Growth Story Keeps Adding Chapters
On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days…
Sun Pharma Requires High Court Approval for Semaglutide Tablet Launch Amid Patent Dispute, ETPharma
New Delhi: The Delhi High Court on Tuesday asked Sun Pharma Laboratories to take its prior approval before…
Amazon Is Bringing the Weight-Loss Drug Race to Medicare
This article first appeared on GuruFocus. Amazon.com Inc. (AMZN, Financials), the e-commerce and cloud-computing company, is expanding its…
Hairdressers selling ‘Ozempic’: SA’s wild weight loss market
A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done…
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
Novo Nordisk A/S Bagsværd, Denmark, 31 July 2026 – Novo Nordisk today announced headline results from the ZEUS cardiovascular…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
Eli Lilly’s Anticipated Weight Loss Drug Helped People Lose 56 Pounds On Average
Topline Eli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
Novo Nordisk Launches Affordable Ozempic Copy in South Africa, ETPharma
Johannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa…
The Latest Ozempic Side Effect? It May Make You Less Violent
Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to Accelerate
tablets pills medicine bottle NEW SIZE ©PXHere Novo Nordisk (NYSE:NVO) is seeing strong uptake of its oral Wegovy…
Generic semaglutide market shows signs of excess inventory bulge | Industry News
Pharmarack data indicates elevated stock levels across several recently launched brands amid slower-than-expected liquidation in the trade…